SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (322)2/13/1999 2:09:00 PM
From: NeuroInvestment  Read Replies (1) of 626
 
Rick: Nice pickup on this citation, as a hypothesis for atypical drug effects on so-called negative symptoms, and supporting iloperidone's effects therein. Obliquely off topic, it also adds to one's interest in the Gliatech H3 program--while I have yet to be all that impressed with atypical antipsychotics so far as upregulating cognition in sz is concerned, they have a lot of 'noise' built in via their other multiple receptor effects, and the disorder itself. A pure H3 antagonist working in a 'pure' cognitive enhancement paradigm could be very intriguing.
NeuroInvestment (www.neuroinvestment.com)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext